Vir Biotechnology (VIR) Trades Higher in Sympathy with Janux Therapeutics (JANX)
Tweet
Share
E-mail
Get Alerts VIR Hot Sheet
Join SI Premium – FREE
Vir Biotechnology Inc. (NASDAQ: VIR) Trades Higher in Sympathy with Janux Therapeutics (NASDAQ: JANX)
- Janux Therapeutics Surges 40% After Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WW International (WW), Lender Advisors Commence Talks - Bloomberg
- Stryker (SYK) commences tender offer for all outstanding shares of common stock of Inari Medical
- Moderna (MRNA) Awarded $590M for Bird Flu Vaccine Development - Reuters
Create E-mail Alert Related Categories
Corporate News, Momentum MoversRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
